TrialThe American journal of psychiatry2021

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.

Edward V Nunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.